Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | -0.20% | -6.69% | -19.94% |
Mar. 13 | Transcript : ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | ScPharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Evolution of the average Target Price on scPharmaceuticals Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering scPharmaceuticals Inc.
Craig-Hallum | |
Jefferies & Co. | |
Maxim | |
SVB Securities LLC | |
Cowen | |
HC Wainwright | |
SVB Leerink |
EPS Revisions
- Stock
- Equities
- Stock scPharmaceuticals Inc. - Nasdaq
- Consensus scPharmaceuticals Inc.